These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15233659)

  • 61. Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study.
    Abukhalil AD; Ali O; Saad A; Falana H; Al-Shami N; Naseef HA; Rabba A
    Int J Gen Med; 2023; 16():141-150. PubMed ID: 36659914
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.
    Bashford JN; Norwood J; Chapman SR
    BMJ; 1998 Aug; 317(7156):452-6. PubMed ID: 9703528
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation and management of hypersensitivity to proton pump inhibitors.
    Bose S; Guyer A; Long A; Banerji A
    Ann Allergy Asthma Immunol; 2013 Dec; 111(6):452-7. PubMed ID: 24267357
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource.
    Pollock K; Grime J
    Soc Sci Med; 2000 Dec; 51(12):1827-39. PubMed ID: 11128270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inappropriate Use of Intravenous PPI for Stress Ulcer Prophylaxis in an Inner City Community Hospital.
    Perwaiz MK; Posner G; Hammoudeh F; Schmidt F; Neupane N; Enriquez D; Gulati N
    J Clin Med Res; 2010 Oct; 2(5):215-9. PubMed ID: 21629543
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A survey of gastroprotective drugs: prescription-indication in hospitalized patients].
    Ameijeiras AH; González BC; Zúñiga VL
    Gac Sanit; 2007; 21(5):412-5. PubMed ID: 17916308
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An evaluation of the use of proton pump inhibitors.
    Walker NM; McDonald J
    Pharm World Sci; 2001 Jun; 23(3):116-7. PubMed ID: 11468876
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Cross-Sectional Study on Single-Day Use of Proton Pump Inhibitors in Tertiary Care Hospitals of South India.
    M ZA; Lavu A; Ansari M; V RA; Vilakkathala R
    Hosp Pharm; 2021 Apr; 56(2):109-115. PubMed ID: 33790486
    [No Abstract]   [Full Text] [Related]  

  • 69. Appropriateness of gastric antisecretory therapy in hospital practice.
    Sebastian SS; Kernan N; Qasim A; O'Morain CA; Buckley M
    Ir J Med Sci; 2003; 172(3):115-7. PubMed ID: 14700112
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Pattern of Intravenous Proton-Pump Inhibitor Utilization at an Academic Medical Center in Riyadh, Saudi Arabia.
    Mohzari YA; Alsaegh A; Basheeruddin Asdaq SM; Al Shanawani SN; Albraiki AA; Bagalb A
    J Res Pharm Pract; 2020; 9(3):151-154. PubMed ID: 33489984
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The rise and rise of proton pump inhibitor drugs: patients' perspectives.
    Boath EH; Blenkinsopp A
    Soc Sci Med; 1997 Nov; 45(10):1571-9. PubMed ID: 9351147
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of proton-pump inhibitor use at a tertiary teaching hospital in Nigeria.
    Okoro RN; Abdullahi K; Dayar DA
    Med Access Point Care; 2021; 5():23992026211062729. PubMed ID: 36204491
    [TBL] [Abstract][Full Text] [Related]  

  • 73. INAPPROPRIATE USAGE OF INTRAVENOUS PROTON PUMP INHIBITORS AND ASSOCIATED FACTORS IN A HIGH COMPLEXITY HOSPITAL IN BRAZIL.
    Bischoff LM; Faraco LSM; Machado LV; Bialecki AVS; Almeida GM; Becker SCC
    Arq Gastroenterol; 2021; 58(1):32-38. PubMed ID: 33909794
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The prevalence of pantoprozole associated thrombocytopenia in a community hospital.
    Dotan E; Katz R; Bratcher J; Wasserman C; Liebman M; Panagopoulos G; Spaccavento C
    Expert Opin Pharmacother; 2007 Sep; 8(13):2025-8. PubMed ID: 17714057
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors.
    Alhossan A; Alrabiah Z; Alghadeer S; Bablghaith S; Wajid S; Al-Arifi M
    Saudi Pharm J; 2019 Feb; 27(2):225-228. PubMed ID: 30766433
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use.
    de Araújo LML; de Moura Lopes MV; de Arruda RS; Martins RR; Oliveira AG
    PLoS One; 2021; 16(6):e0252785. PubMed ID: 34111166
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Strategies for reduction in the duration of intravenous drug use: Interest of drug tracers as quality indicators to improve intravenous to oral switch.
    Corny J; Perreau S; Thivilliers AP; Leplay C; Chevalier D; Beaussier H; Bézie Y
    J Eval Clin Pract; 2017 Aug; 23(4):848-852. PubMed ID: 28271587
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Imprudent Gastro-protective Approach in Majority of Specialists' Clinics of a Tertiary Hospital.
    Patel HR; Dhande P
    J Clin Diagn Res; 2016 Mar; 10(3):FC12-5. PubMed ID: 27134889
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Attitude and Knowledge of Indian Emergency Care Residents towards Use of Proton Pump Inhibitors.
    Padhy BM; Bhadauria HS; Gupta YK
    Int Sch Res Notices; 2014; 2014():968430. PubMed ID: 27382625
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Audit of IV pantoprazole: pattern of administration and compliance with guideline in a teaching hospital.
    Moradi M; Raeesi S; Sepehri Z
    Springerplus; 2016; 5(1):1749. PubMed ID: 27795892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.